Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 3
2006 2
2007 6
2008 7
2009 8
2010 7
2011 9
2012 16
2013 21
2014 17
2015 15
2016 12
2017 23
2018 26
2019 24
2020 27
2021 16
2022 33
2023 37
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year

Filters applied: . Clear all
Page 1
Validation of the imatinib-therapy failure model.
Zhang X, Gale RP, Liu B, Huang J, Zhang Y, Du X, Weng J, Li W, Xu N, Liu X, Chen C, Lin H, Li G, Liang R, Liu Z, Wang X, Zhang Y, Han Y, Liu C, Hu J, Lin L, Yang W, Liu Z, Meng L, Tu C, Zheng C, Zhou Z, Bai Y, Qiu H, Chen S, Li F, Guo J, Liu Z, Sun H, Zhou L, Feng R, Sun X, Huang X, Jiang Q. Zhang X, et al. Among authors: zhang y. Leukemia. 2023 May;37(5):1166-1169. doi: 10.1038/s41375-023-01875-3. Epub 2023 Mar 27. Leukemia. 2023. PMID: 36973351 No abstract available.
New Loss-of-Function Mutations in PCSK9 Reduce Plasma LDL Cholesterol.
Meng FH, Liu S, Xiao J, Zhou YX, Dong LW, Li YF, Zhang YQ, Li WH, Wang JQ, Wang Y, Song BL, Ma YT, Fu ZY, Luo J. Meng FH, et al. Arterioscler Thromb Vasc Biol. 2023 Jul;43(7):1219-1233. doi: 10.1161/ATVBAHA.122.318839. Epub 2023 May 11. Arterioscler Thromb Vasc Biol. 2023. PMID: 37165876
TRPA1: A promising target for pulmonary fibrosis?
Li C, Xu J, Abdurehim A, Sun Q, Xie J, Zhang Y. Li C, et al. Among authors: zhang y. Eur J Pharmacol. 2023 Nov 15;959:176088. doi: 10.1016/j.ejphar.2023.176088. Epub 2023 Sep 28. Eur J Pharmacol. 2023. PMID: 37777106 Review.
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Yang S, Zhang X, Gale RP, Du X, Chen CY, Weng JY, Huang J, Li F, Zeng Y, Xiao Z, Hu JD, Yang LJ, Liu ZG, Li GH, Sun XL, Yang W, Feng R, Han YQ, Jing Y, Xu N, Liu XL, Liu ZF, Wang XD, Wu SX, Liang R, Zhang YL, Yang YF, Zhu HL, Pan L, Meng L, Zhao YH, Yi H, Liu YL, Zhang WH, Zheng YJ, Zhou ZP, Chen SN, Qiu HY, Li WM, Jia ZL, Bai YL, Lin LE, Liu BC, Liu CS, Luo JM, Meng JX, Sun ZQ, Zhang YQ, Huang XJ, Jiang Q. Yang S, et al. Am J Hematol. 2023 Jul;98(7):E183-E186. doi: 10.1002/ajh.26943. Epub 2023 May 2. Am J Hematol. 2023. PMID: 37128776 No abstract available.
Research Progress on Antiviral Activity of Heparin.
Wang Y, Zhang Y, Wang P, Jing T, Hu Y, Chen X. Wang Y, et al. Among authors: zhang y. Curr Med Chem. 2024;31(1):7-24. doi: 10.2174/0929867330666230203124032. Curr Med Chem. 2024. PMID: 36740803 Review.
283 results